Africa (WHO region) vs Fiji: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Africa (WHO region)
89.0%
in 2014
Fiji
100.0%
in 2014
Africa (WHO region) rank
2nd
Fiji rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Africa (WHO region)
- Fiji
How they compare
Fiji currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.
That makes Fiji's figure about 1.1 times Africa (WHO region)'s.
The two have swapped places 1 time across 6 shared years of data; in 2006 it was Africa (WHO region) ahead.
Africa (WHO region) ranks 2nd and Fiji ranks 1st of 11 groups.
Across the 2 decades both report, Africa (WHO region) averaged higher in 1 and Fiji in 1.
Head to head by decade
| Decade | Africa (WHO region) | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.0% | 67.0% | 20.0% | Africa (WHO region) |
| 2010s | 85.0% | 100.0% | 15.0% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Fiji?
- Fiji, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Fiji?
- 11.0%, with Fiji ahead.
- How many years of comparable data are there for Africa (WHO region) and Fiji?
- 6 years are reported by both, from 2006 to 2014.
- How do Africa (WHO region) and Fiji rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Africa (WHO region) ranks 2nd and Fiji ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.